HomeCLN • WSE
add
Celon Pharma SA
Previous close
zł 22.00
Day range
zł 21.60 - zł 22.30
Year range
zł 20.85 - zł 30.20
Market cap
1.17B PLN
Avg Volume
14.88K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 55.82M | -14.94% |
Operating expense | 52.22M | -5.43% |
Net income | -32.76M | -308.26% |
Net profit margin | -58.70 | -379.97% |
Earnings per share | — | — |
EBITDA | -8.28M | -247.43% |
Effective tax rate | -22.05% | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 38.98M | -67.81% |
Total assets | 482.63M | -16.26% |
Total liabilities | 97.52M | -16.62% |
Total equity | 385.11M | — |
Shares outstanding | 53.86M | — |
Price to book | 3.08 | — |
Return on assets | -8.30% | — |
Return on capital | -9.87% | — |
Cash Flow
Net change in cash
| (PLN) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -32.76M | -308.26% |
Cash from operations | 3.51M | 181.11% |
Cash from investing | -1.56M | 81.29% |
Cash from financing | -2.95M | -111.77% |
Net change in cash | -993.00K | -108.01% |
Free cash flow | -13.75M | -654.27% |
About
Founded
2002
Website
Employees
568
